The Parsortix™ Cell Separation System—A versatile liquid biopsy platform

Volume: 93, Issue: 12, Pages: 1234 - 1239
Published: Aug 14, 2018
Abstract
Cancer cells from solid tumors can enter the circulatory system and survive to subsequently form distant metastases. The CellSearch® system (Menarini-Silicon Biosystems, Huntingdon Valley, PA) was the first, FDA-cleared system that provided a reliable tool for the investigation of circulating tumor cells (CTCs), which have been shown to be strongly associated with poor survival and therapy failure. Since that time, a number of new technologies...
Paper Details
Title
The Parsortix™ Cell Separation System—A versatile liquid biopsy platform
Published Date
Aug 14, 2018
Volume
93
Issue
12
Pages
1234 - 1239
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.